P Pharma

4P-Pharma is a clinical-stage biotechnology company based in Lille, France, that specializes in drug regeneration and repurposing. Founded in 2014, the company operates as a 'startup studio' for drug development, identifying high-potential early-stage molecules from academic research and accelerating them through clinical proof-of-concept. Its business model involves forming Single Product Vehicles (SPVs) to focus on specific therapeutic candidates, primarily targeting chronic and autoimmune diseases with high unmet medical needs. Key programs in its pipeline include treatments for knee osteoarthritis, dry age-related macular degeneration, and rare inflammatory conditions. The company leverages a proprietary development engine to reduce the time, cost, and risk associated with traditional drug development.